Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictors of the Unfavourable Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase, a Multi-centre Prospective Study

NCT06058884 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT06058884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06058884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictors of the Unfavourable Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase, a Multi-centre Prospective Study
Lead sponsor
Kafrelsheikh University
Phase
Phase 4
Overall status
Completed
Start date
January 3, 2022
Completion date
June 29, 2023
Enrollment
592 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alteplase adverse reaction, ischemic stroke